Key Facts GPs Should Know About GLP-1 Analogs
Family Medicine Initiative
APRIL 9, 2024
Cardiovascular Events The SELECT trial 1 randomized 17,604 patients with preexisting CVD and overweight/obesity. Relative risk for cardiovascular events was reduced by 19% (RRR), while the absolute risk was reduced by 1.5% 5 In March 2024, Novo Nordisk announced that 24% less CKD-related events occurred in the intervention group.
Let's personalize your content